Pharmaceutical

Bavarian Nordic seeks authorisation for mpox vaccine’s use in adolescents

Bavarian Nordic aims to gain a label expansion for adolescents in Europe in Q4 this year, whilst it prepares a trial in children in Africa.

Aug 17, 2024 - 04:00
Bavarian Nordic seeks authorisation for mpox vaccine’s use in adolescents
Bavarian Nordic aims to gain a label expansion for adolescents in Europe in Q4 this year, whilst it prepares a trial in children in Africa.
Read the original article

Tags:

Previous Article

AstraZeneca wins approval for Imfinzi in NSCLC perioperative setting

Next Article

Armed with Phase III win, Incyte eyes label expansion for Monjuvi

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

A broad genetic test saved one newborn’s life. Research suggests it could help millions of others

A broad genetic test saved one newborn’s life. Research...

Aug 29, 2023

FDA shuns Outlook Therapeutics with wet AMD drug BLA rejection

FDA shuns Outlook Therapeutics with wet AMD drug BLA re...

Aug 30, 2023

SGNB-7H4V by Pfizer for Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer): Likelihood of Approval

SGNB-7H4V by Pfizer for Human Epidermal Growth Factor R...

Jun 20, 2024